NCT05860933View on ClinicalTrials.gov

A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

August 28, 2023

Study Completion Date

August 28, 2023

Conditions

Healthy

Interventions

DRUG

LY3537982

Administered orally.

DRUG

Itraconazole

Administered orally.

DRUG

Carbamazepine

Administered orally.

Trial Locations (2)

78209

ICON Early Development Services, San Antonio

84124

ICON Early Development Services, Salt Lake City

Sponsors

Collaborators (1)

Loxo Oncology, Inc.

All Listed Sponsors

collaborator

Loxo Oncology, Inc.

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY